1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Platelet Transfusion 1.2.3 Recombinant Activated Factor VII 1.2.4 Antifibrinolytics 1.2.5 Fibrin Sealants 1.2.6 Thrombin 1.2.7 Desmopressin 1.3 Market by Application 1.3.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2020 VS 2026 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Perspective (2015-2026) 2.2 Global Glanzmann Thrombasthenia Therapeutic Drug Growth Trends by Regions 2.2.1 Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Glanzmann Thrombasthenia Therapeutic Drug Historic Market Share by Regions (2015-2020) 2.2.3 Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Market Size 3.1.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue (2015-2020) 3.1.2 Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Players (2015-2020) 3.2 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Glanzmann Thrombasthenia Therapeutic Drug Revenue 3.4 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio 3.4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2019 3.5 Key Players Glanzmann Thrombasthenia Therapeutic Drug Area Served 3.6 Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service 3.7 Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Type (2015-2026) 4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Type (2015-2020) 4.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2021-2026) 5 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Application (2015-2026) 5.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Application (2015-2020) 5.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2015-2026) 6.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) 6.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) 6.4 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size (2015-2026) 7.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) 7.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) 7.4 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Glanzmann Thrombasthenia Therapeutic Drug Market Size (2015-2026) 8.2 China Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) 8.3 China Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) 8.4 China Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size (2015-2026) 9.2 Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) 9.3 Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) 9.4 Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size (2015-2026) 10.2 Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) 10.3 Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) 10.4 Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Novo Nordisk 11.1.1 Novo Nordisk Company Details 11.1.2 Novo Nordisk Business Overview 11.1.3 Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.1.4 Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020)) 11.1.5 Novo Nordisk Recent Development 11.2 Alnylam Pharmaceuticals 11.2.1 Alnylam Pharmaceuticals Company Details 11.2.2 Alnylam Pharmaceuticals Business Overview 11.2.3 Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.2.4 Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.2.5 Alnylam Pharmaceuticals Recent Development 11.3 Shire (Takeda) 11.3.1 Shire (Takeda) Company Details 11.3.2 Shire (Takeda) Business Overview 11.3.3 Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.3.4 Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.3.5 Shire (Takeda) Recent Development 11.4 Biogen 11.4.1 Biogen Company Details 11.4.2 Biogen Business Overview 11.4.3 Biogen Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.4.4 Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.4.5 Biogen Recent Development 11.5 Bioverativ (Sanofi) 11.5.1 Bioverativ (Sanofi) Company Details 11.5.2 Bioverativ (Sanofi) Business Overview 11.5.3 Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.5.4 Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.5.5 Bioverativ (Sanofi) Recent Development 11.6 Bayer 11.6.1 Bayer Company Details 11.6.2 Bayer Business Overview 11.6.3 Bayer Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.6.4 Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.6.5 Bayer Recent Development 11.7 CSL Behring 11.7.1 CSL Behring Company Details 11.7.2 CSL Behring Business Overview 11.7.3 CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.7.4 CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.7.5 CSL Behring Recent Development 11.8 Grifols 11.8.1 Grifols Company Details 11.8.2 Grifols Business Overview 11.8.3 Grifols Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.8.4 Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.8.5 Grifols Recent Development 11.9 Bristol-Myers Squibb 11.9.1 Bristol-Myers Squibb Company Details 11.9.2 Bristol-Myers Squibb Business Overview 11.9.3 Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.9.4 Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.9.5 Bristol-Myers Squibb Recent Development 11.10 Pfizer 11.10.1 Pfizer Company Details 11.10.2 Pfizer Business Overview 11.10.3 Pfizer Glanzmann Thrombasthenia Therapeutic Drug Introduction 11.10.4 Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) 11.10.5 Pfizer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Platelet Transfusion Table 4. Key Players of Recombinant Activated Factor VII Table 5. Key Players of Antifibrinolytics Table 6. Key Players of Fibrin Sealants Table 7. Key Players of Thrombin Table 8. Key Players of Desmopressin Table 9. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2015-2020) Table 13. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2021-2026) Table 15. Glanzmann Thrombasthenia Therapeutic Drug Market Market Trends Table 16. Glanzmann Thrombasthenia Therapeutic Drug Market Drivers Table 17. Glanzmann Thrombasthenia Therapeutic Drug Market Challenges Table 18. Glanzmann Thrombasthenia Therapeutic Drug Market Restraints Table 19. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue by Players (2015-2020) (US$ Million) Table 20. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players (2015-2020) Table 21. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2019) Table 22. Global Glanzmann Thrombasthenia Therapeutic Drug by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) (US$ Million) Table 27. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Type (2015-2020) Table 28. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2021-2026) Table 29. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Application (2015-2020) Table 30. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) (US$ Million) Table 31. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Share by Application (2021-2026) Table 32. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) (US$ Million) Table 33. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2015-2020) Table 34. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) (US$ Million) Table 35. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2015-2020) Table 36. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (US$ Million) (2015-2020) Table 37. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2015-2020) Table 38. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) (US$ Million) Table 39. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2015-2020) Table 40. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) (US$ Million) Table 41. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2015-2020) Table 42. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (US$ Million) (2015-2020) Table 43. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2015-2020) Table 44. China Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) (US$ Million) Table 45. China Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2015-2020) Table 46. China Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) (US$ Million) Table 47. China Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2015-2020) Table 48. China Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (US$ Million) (2015-2020) Table 49. China Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region (2015-2020) Table 50. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) (US$ Million) Table 51. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2015-2020) Table 52. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) (US$ Million) Table 53. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2015-2020) Table 54. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (US$ Million) (2015-2020) Table 55. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2015-2020) Table 56. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2015-2020) (US$ Million) Table 57. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type (2015-2020) Table 58. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2015-2020) (US$ Million) Table 59. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application (2015-2020) Table 60. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (US$ Million) (2015-2020) Table 61. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2015-2020) Table 62. Novo Nordisk Company Details Table 63. Novo Nordisk Business Overview Table 64. Novo Nordisk Product Table 65. Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 66. Novo Nordisk Recent Development Table 67. Alnylam Pharmaceuticals Company Details Table 68. Alnylam Pharmaceuticals Business Overview Table 69. Alnylam Pharmaceuticals Product Table 70. Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 71. Alnylam Pharmaceuticals Recent Development Table 72. Shire (Takeda) Company Details Table 73. Shire (Takeda) Business Overview Table 74. Shire (Takeda) Product Table 75. Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 76. Shire (Takeda) Recent Development Table 77. Biogen Company Details Table 78. Biogen Business Overview Table 79. Biogen Product Table 80. Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 81. Biogen Recent Development Table 82. Bioverativ (Sanofi) Company Details Table 83. Bioverativ (Sanofi) Business Overview Table 84. Bioverativ (Sanofi) Product Table 85. Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 86. Bioverativ (Sanofi) Recent Development Table 87. Bayer Company Details Table 88. Bayer Business Overview Table 89. Bayer Product Table 90. Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 91. Bayer Recent Development Table 92. CSL Behring Company Details Table 93. CSL Behring Business Overview Table 94. CSL Behring Product Table 95. CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 96. CSL Behring Recent Development Table 97. Grifols Business Overview Table 98. Grifols Product Table 99. Grifols Company Details Table 100. Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 101. Grifols Recent Development Table 102. Bristol-Myers Squibb Company Details Table 103. Bristol-Myers Squibb Business Overview Table 104. Bristol-Myers Squibb Product Table 105. Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 106. Bristol-Myers Squibb Recent Development Table 107. Pfizer Company Details Table 108. Pfizer Business Overview Table 109. Pfizer Product Table 110. Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) (US$ Million) Table 111. Pfizer Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type: 2020 VS 2026 Figure 2. Platelet Transfusion Features Figure 3. Recombinant Activated Factor VII Features Figure 4. Antifibrinolytics Features Figure 5. Fibrin Sealants Features Figure 6. Thrombin Features Figure 7. Desmopressin Features Figure 8. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2020 VS 2026 Figure 9. Hospital Case Studies Figure 10. Clinic Case Studies Figure 11. Others Case Studies Figure 12. Glanzmann Thrombasthenia Therapeutic Drug Report Years Considered Figure 13. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size (US$ Million), YoY Growth 2015-2026 Figure 14. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions: 2020 VS 2026 Figure 15. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Regions (2021-2026) Figure 16. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players in 2019 Figure 17. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2019 Figure 19. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. United States Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Germany Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. France Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. U.K. Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Italy Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Russia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Nordic Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Rest of Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. China Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. South Korea Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. India Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Australia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Mexico Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Brazil Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Turkey Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Saudi Arabia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. UAE Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Rest of Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. Novo Nordisk Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 47. Alnylam Pharmaceuticals Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 48. Shire (Takeda) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 49. Biogen Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 50. Bioverativ (Sanofi) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 51. Bayer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 52. CSL Behring Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 53. Grifols Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 55. Pfizer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2015-2020) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Novo Nordisk Alnylam Pharmaceuticals Shire (Takeda) Biogen Bioverativ (Sanofi) Bayer CSL Behring Grifols Bristol-Myers Squibb Pfizer